Concourse Financial Group Securities’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 2590 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 4179 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 4176 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 4214 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 4226 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 4165 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 4125 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 4076 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 3981 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 3951 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 3735 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 3783 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 3729 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 3845 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 3788 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 3680 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 3603 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 3528 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 3371 |
|
|
2020
Q2 | – | Sell |
-10,779
| Closed | -$678K | – | 3273 |
|
|
2020
Q1 | $678K | Buy |
+10,779
| New | +$678K | 0.07% | 203 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 3246 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 2963 |
|
|
2019
Q2 | – | Sell |
-7,566
| Closed | -$482K | – | 3286 |
|
|
2019
Q1 | $482K | Buy |
7,566
+3,153
| +71% | +$201K | 0.05% | 273 |
|
|
2018
Q4 | $225K | Buy |
4,413
+4,353
| +7,255% | +$222K | 0.03% | 408 |
|
|
2018
Q3 | $3K | Buy |
+60
| New | +$3K | ﹤0.01% | 1504 |
|